Corona Remedies IPO Sees Strong Demand

Corona Remedies, a medicine company, started selling shares to the public for the first time.

On the first day, they sold 62% of the shares they offered.

People who buy small amounts of shares, called retail investors, bought 87% of their share, and other big investors bought 79%.

But big institutions didn't buy any shares yet.

The company is worth about Rs 6,500 crore, and the shares cost between Rs 1,008 and Rs 1,062 each.

The company makes medicines for women's health, heart and diabetes, pain, and other areas.

They will start selling shares on the stock market on December 15.

By midday on the last day, Corona Remedies saw a huge demand with 31.59 times subscription, while another company, Wakefit, had a much lower demand with only 0.60 times subscription.

Corona Remedies' IPO is only selling existing shares, while Wakefit's IPO includes new shares and money for growing their business.

Both companies will start trading on the stock market on December 15, 2025.